Vascular Biogen. Ord (VBLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VBLT | AMGN | VRTX | REGN | GSK |
| Company | Vascular Biogen. Ord | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 6.0690 | 301.29 | 478.00 | 1,014.81 | 41.36 |
| High | 6.7375 | 303.54 | 481.71 | 1,030.00 | 41.38 |
| Low | 5.3410 | 299.43 | 473.51 | 1,009.15 | 40.97 |
| Last | 5.4600 | 301.08 | 475.79 | 1,027.67 | 41.11 |
| Change | -0.5250 | +0.38 | -5.74 | +17.13 | +0.05 |
| % Change | -8.77% | +0.13% | -1.19% | +1.70% | +0.12% |
| Volume | 161,505 | 1,640,000 | 1,245,000 | 453,600 | 2,548,500 |
| 20-Day Average Volume | 1,006,195 | 2,295,185 | 1,237,555 | 399,110 | 4,201,845 |
| Previous Close | 5.9850 | 300.70 | 481.53 | 1,010.54 | 41.06 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2249 | 307.01 | 459.51 | 989.06 | 43.42 |
| 20-Day Raw Stochastic | 2.51% | 21.54% | 81.60% | 97.00% | 11.08% |
| 20-Day Relative Strength | 35.56% | 52.02% | 68.07% | 67.77% | 41.19% |
| Weighted Alpha | +1.00 | +27.47 | +41.59 | +34.31 | +15.43 |
| Today's Opinion | 40% Sell | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 40% Sell | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 24% Buy | 56% Buy | 56% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -33.76% since 10/09/23 | -2.05% since 06/05/24 | -1.50% since 06/05/24 | +2.17% since 06/05/24 | -2.05% since 06/05/24 |
| Low | 0.1526 on 10/16/23 | 299.43 on 06/12/24 | 473.51 on 06/12/24 | 992.22 on 06/10/24 | 40.89 on 06/11/24 |
| High | 0.2880 on 10/12/23 | 310.01 on 06/06/24 | 486.42 on 06/07/24 | 1,030.00 on 06/12/24 | 42.00 on 06/06/24 |
| 1-Month | |||||
| %Chg | -33.33% since 09/15/23 | -2.92% since 05/10/24 | +12.54% since 05/10/24 | +5.53% since 05/10/24 | -8.79% since 05/10/24 |
| Low | 0.1526 on 10/16/23 | 295.49 on 05/30/24 | 422.44 on 05/14/24 | 952.30 on 05/30/24 | 40.51 on 06/03/24 |
| High | 0.2880 on 10/12/23 | 321.44 on 05/15/24 | 486.42 on 06/07/24 | 1,030.00 on 06/12/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -46.99% since 07/14/23 | +8.87% since 03/12/24 | +15.36% since 03/12/24 | +5.88% since 03/12/24 | -4.99% since 03/12/24 |
| Low | 0.1526 on 10/16/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 0.3098 on 07/25/23 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 1,030.00 on 06/12/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -20.93% since 04/14/23 | +9.89% since 12/12/23 | +33.00% since 12/12/23 | +18.98% since 12/12/23 | +12.88% since 12/12/23 |
| Low | 0.1520 on 04/25/23 | 260.68 on 04/19/24 | 372.80 on 12/13/23 | 838.46 on 12/21/23 | 35.87 on 12/15/23 |
| High | 0.3200 on 07/13/23 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,030.00 on 06/12/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,112 | 161,306,016 | 124,260,272 | 111,347,352 | 85,094,392 |
| Shares Outstanding, K | 77,640 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 660,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -32,300,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -870,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.76 | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 08/14/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 11/13/23 | 08/01/24 | 08/06/24 | 08/01/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.36 | 32.09 | 26.99 | 10.22 |